<DOC>
	<DOCNO>NCT01027208</DOCNO>
	<brief_summary>To provide extended access Ixabepilone therapy subject metastatic breast cancer complete previous Phase II study ( CA163-107 )</brief_summary>
	<brief_title>A Rollover Study Ixabepilone ( BMS-247550 ) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Women age 20 year old Patients metastatic breast cancer whose primary lesion definitely diagnose breast histological cellular examination Patients Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) â‰¥2</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>